Trial Profile
Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Factor VIII inhibitor bypassing fraction (Primary)
- Indications Haemophilia A; Haemorrhage
- Focus Pharmacodynamics
- 27 Jan 2014 New trial record